Michigan Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Michigan Technology Journal.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 17, 2026

13 hours ago

Ex-White House Spokesman Bob Weiner Applauds National Launch of The Bankole Thompson Center

EIN Presswire

14 hours ago

Crypto News: AlphaPepe Announces $870k Raised Amid Dogecoin Price Prediction Targeting $0.47 Following X Money Beta Launch

GlobeNewswire

15 hours ago

Fyresite Reaches New Heights With Shopify Premier Partner Promotion

GlobeNewswire

15 hours ago

Rocket Doctor Amends 45 Degree Agreement

GlobeNewswire

15 hours ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

16 hours ago

Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting

GlobeNewswire

16 hours ago

Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

GlobeNewswire

16 hours ago

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

16 hours ago

BGIN BLOCKCHAIN LIMITED Schedules the Fiscal Year 2025 Earnings and Conference Call on April 24, 2026

GlobeNewswire

16 hours ago

TTEC Schedules First Quarter 2026 Earnings Release and Webcast of Investor Conference Call

GlobeNewswire

16 hours ago

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

GlobeNewswire

16 hours ago

Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting

GlobeNewswire

16 hours ago

4DMT Announces New Employment Inducement Grants

GlobeNewswire

16 hours ago

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

16 hours ago

SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders

GlobeNewswire

16 hours ago

ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire

16 hours ago

Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026

GlobeNewswire

17 hours ago

Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

17 hours ago

Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types

GlobeNewswire

17 hours ago

Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2

GlobeNewswire